These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 795225)
1. [Enhancement of toxin production and sporogenesis in Cl. tetani 471 cultures under the influence of endogenous metabolites]. Korovina VP; Chikishev EV; Vaĭsman ISh Zh Mikrobiol Epidemiol Immunobiol; 1976 Oct; (10):102-6. PubMed ID: 795225 [TBL] [Abstract][Full Text] [Related]
2. Growth and toxin production of Tetanus bacilli in vivo. Smith JW; MacIver AG J Med Microbiol; 1974 Nov; 7(4):497-504. PubMed ID: 4615153 [No Abstract] [Full Text] [Related]
3. [Study on the effect of a biostimulant on the growth and toxigenic function of Clostridium tetani strain Copenhagen-471]. Garib FIu; Petrov VIu; Komarova EA; Sheremet'ev NN Zh Mikrobiol Epidemiol Immunobiol; 2002; (6):73-5. PubMed ID: 12506634 [TBL] [Abstract][Full Text] [Related]
4. Clostridium tetani growth and toxin production in the intestines of germfree rats. Wells CL; Balish E Infect Immun; 1983 Aug; 41(2):826-8. PubMed ID: 6347898 [TBL] [Abstract][Full Text] [Related]
5. Nitrogen-gas bubbling during the cultivation of Clostridium tetani produces a higher yield of tetanus toxin for the preparation of its toxoid. De Luca MM; Abeiro HD; Bernagozzi JA; Basualdo JA Microbiol Immunol; 1997; 41(2):161-3. PubMed ID: 9087958 [TBL] [Abstract][Full Text] [Related]
6. [Toxinogenesis of Plectridium tetani]. Vinet G; Fredette V Can J Microbiol; 1970 Nov; 16(11):1067-70. PubMed ID: 4923480 [No Abstract] [Full Text] [Related]
7. Tetanus toxin production is triggered by the transition from amino acid consumption to peptides. Licona-Cassani C; Steen JA; Zaragoza NE; Moonen G; Moutafis G; Hodson MP; Power J; Nielsen LK; Marcellin E Anaerobe; 2016 Oct; 41():113-124. PubMed ID: 27492724 [TBL] [Abstract][Full Text] [Related]
8. A particular culture character of Clostridium tetani. Bittner J; Antohi M Arch Roum Pathol Exp Microbiol; 1982; 41(3):205-12. PubMed ID: 6760831 [No Abstract] [Full Text] [Related]
9. The effect of glutamate on toxin production by Clostridium tetani. Mellanby J J Gen Microbiol; 1968 Nov; 54(1):77-82. PubMed ID: 4891918 [No Abstract] [Full Text] [Related]
10. Continuous production of Clostridium tetani toxin. Zacharias B; Björklund M Appl Microbiol; 1968 Jan; 16(1):69-72. PubMed ID: 4865906 [TBL] [Abstract][Full Text] [Related]
11. Production of toxic antigens in dialyzed cultures of microorganisms. Vraný B; Hnátková Z; Lettl A Folia Microbiol (Praha); 1988; 33(2):148-54. PubMed ID: 3286420 [TBL] [Abstract][Full Text] [Related]
12. [Fine morphology of the anomalies of sporulation in Clostridium tetani]. Vaĭsman ISh Zh Mikrobiol Epidemiol Immunobiol; 1982 Oct; (10):43-7. PubMed ID: 6758430 [TBL] [Abstract][Full Text] [Related]
13. Fed-batch production of tetanus toxin by Clostridium tetani. Fratelli F; Siquini TJ; de Abreu ME; Higashi HG; Converti A; de Carvalho JC Biotechnol Prog; 2010; 26(1):88-92. PubMed ID: 19856382 [TBL] [Abstract][Full Text] [Related]
14. A defined medium for the growth of Clostridium tetani and other anaerobes of clinical interest. Watt B; Brown R J Med Microbiol; 1975 Feb; 8(1):167-72. PubMed ID: 1092864 [TBL] [Abstract][Full Text] [Related]
15. [Influence of the method of culture on the toxin production of Plectridium tetani]. Vinet G; Fredette V Can J Microbiol; 1970 Feb; 16(2):135-6. PubMed ID: 4907028 [No Abstract] [Full Text] [Related]
16. Effect of medium composition on the production of tetanus toxin by Clostridium tetani. Fratelli F; Siquini TJ; Prado SM; Higashi HG; Converti A; de Carvalho JC Biotechnol Prog; 2005; 21(3):756-61. PubMed ID: 15932253 [TBL] [Abstract][Full Text] [Related]
17. [Use of a synthetic medium for cultivating pathogenic anaerobes]. Ivanova LG; Sergeeva TI Zh Mikrobiol Epidemiol Immunobiol; 1975 Mar; 0(3):40-3. PubMed ID: 164749 [TBL] [Abstract][Full Text] [Related]
18. Effective levels of tetanus toxin can be made in a production medium totally lacking both animal (e.g., brain heart infusion) and dairy proteins or digests (e.g., casein hydrolysates). Demain AL; Gerson DF; Fang A Vaccine; 2005 Nov; 23(46-47):5420-3. PubMed ID: 16122852 [TBL] [Abstract][Full Text] [Related]